Crazy theory: Trump is against paracetamol because the tariffs backfired

I promise I’ll put down the edibles, but hear me out: if the active pharmaceutical ingredient (API) constitutes 52% of the production costs of US-made drugs, then a country with no notable paracetamol API capacity is in for a bad time.

According to this: India and the EU dominate API manufacturing for the most-used ATC-3 therapeutic classes in the U.S. market | Quality Matters | U.S. Pharmacopeia Blog the US local capacity is concentrated around cheaper additives and supplements - multivitamins, etc…

Just judging on the major Panado players like China and India, Kenvue (the now US-owned artist formerly in the J&J superband) would be facing Tylenol production cost increases of between 10- and 127% just because of the spike in raw material tariffs.

Kenvue’s share price has recovered since the brainworm farts from the US health department, but it is an interesting rabbit hole.

3 Likes

There are many Engish words Trump does not understand - tariffs being just one. The rule describing unintended consequences contains far too many unintelligible words.

3 Likes

With these guys, if it seems like some special interest might have planted the idea in his head, it’s probably true. These corporates probably can’t believe they found a putty so easy to mould (not to even mention certain megolomaniacal world leaders).

2 Likes

My big issue with this whole situation is how backward it feels like we have gone. I grew up during the vaccine/autism conspiracy. It feels like we are right back there, 20 years later, having learned nothing.

1 Like